US Gets Third COVID-19 Vaccine As FDA Clears Johnson & Johnson Shot For Emergency Use

<p>In a major blow to the United Stated amid battle against the novel Coronavirus, the Food and Drug Administration (FDA) on Saturday authorised Johnson &amp; Johnson's single-shot Covid vaccine for emergency use. With this, the US has got its third vaccine to battle the Coronavirus outbreak that has killed more than 500,000 across America.&nbsp;</p> <p>The acting FDA director Janet Woodcock in a statement said, "The authorization of this vaccine expands the availability of vaccines, the best medical prevention method for Covid-19, to help us in the fight against this pandemic, which has claimed over half a million lives in the United States."</p> <p><strong>ALSO READ | <a href="https://ift.tt/2ZZkgXW Spike In Covid Case, Pune Schools And Colleges To Remain Shut Till March 14</a></strong></p> <p><strong>Know About Johnson &amp; Johnson Vaccine</strong></p> <p>Johnson &amp; Johnson vaccination offers logistical advantages because of its single-dose and also doesn't require deep-freeze storage, as per the news agency AFP. However, the trials showed the Johnson &amp; Johnson vaccine does not protect as well against a highly transmissible virus variant first identified in South Africa, which is spreading rapidly around the world.&nbsp;</p> <p>It has been overall 66 percent effective, and 85 percent effective in preventing severe forms of the disease, as per the company.&nbsp;The company will be able &nbsp;deliver 100 million doses to the US by the end of June, a major supply of vaccines in a nation of some 320 million people.&nbsp;</p> <p>Phase 3 clinical trials of Johnson &amp; Johnson AdVac, began in late September with 60000 adult volunteers. It, however, had to pause the advanced clinical trial because of an unexplained illness in one of the volunteers.&nbsp;</p>

from covid-19 https://ift.tt/3qYAcpg